Wordt geladen...
EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy?
Cetuximab improved survival when added to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer. In order to determine those patients who will derive the greatest benefit from the addition of cetuximab, the associations of clinical and tumor features with clinic...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Pioneer Bioscience Publishing Company
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367547/ https://ncbi.nlm.nih.gov/pubmed/25806192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2012.10.09 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|